A Phase 3, Randomized, Multicenter, Open-Label, Parallel-Group Clinical Study Comparing the Safety and Efficacy of MYL-1601D with NovoLog in Type 1 Diabetes Mellitus Patients (Protocol MYL-1601D-3001)

Closed for enrollment

Please contact us for more information or to learn if you are eligible to participate.

A study for patients with Type 1 Diabetes Mellitus that compares the safety and efficacy of MYL-1601D with NovoLog®

5323 S. McColl Rd., Edinburg, TX 78539

(956) 362-2390